Answers are grounded in this paper and cite their sources.
Demonstrates how polyphenol-based hydrogels modulate the tumor microenvironment, suggesting potential for improving cancer therapy.
The tumor microenvironment (TME), a complex milieu characterized by acidity, high redox levels, hypoxia and inflammation, supports tumor progression and contributes to therapeutic failure. Moreover, TME imposes immunosuppression, marked by the infiltration of numerous immunosuppressive cells, which impairs the efficacy of immunotherapy. Polyphenol-based hydrogels (PBHs) have emerged as biocompatible materials for in situ TME modulation, owing to their specific cross-linking structures that endow them with unique features, including intrinsic adhesiveness, antioxidant, anti-inflammatory and immunomodulatory properties. Here, the typical types and representative engineering strategies of intelligent PBHs are first introduced, which are responsive to endogenous signals within TME including pH, reactive oxygen species and glutathione. Then their unique biological properties are summarized. Subsequently, their advances in TME modulation are highlighted, such as intelligent targeted drug delivery and release, reactive oxygen species scavenging, anti-inflammatory effects, and immunosuppressive TME remodeling. Finally, we discuss the challenges and development prospects of PBHs for advanced cancer therapy.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: